Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Home Depot Inc (HD) vs Zoetis Inc (ZTS) Price & Performance

Home Depot IncTrade
Zoetis IncTrade

Price performance (Past 24H)

Key statistics

Home Depot Inc vs Zoetis Inc — how do they compare? Home Depot Inc trades at $294.64 (market cap $294.79B), while Zoetis Inc trades at $73.24 (market cap $30.20B). The key difference: Home Depot Inc is far larger — about 9.8× Zoetis Inc's market cap, and Home Depot Inc pays the higher dividend (3.15%). Which is the better fit depends on your goals — on Pluang, investors hold Home Depot Inc for 139 Days and Zoetis Inc for 70 Days on average.

HDZTS
Market Cap
$294.79B$30.20B
Volume
8,693,9176,175,327
Sector
Consumer CyclicalHealth
52-Week High
$391.90$147.53
52-Week Low
$281.15$69.09
Typical Hold Time
139 Days70 Days
Enterprise Value
$355.27B$37.76B
Dividend Yield
3.15%2.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Home Depot Inc

Home Depot (HD) trades at $285.77, down 0.32% on the day, with a bearish technical signal despite strong analyst support. The stock shows consistent earnings beats in recent quarters with Q2 2026 EPS of $4.92 exceeding expectations. Revenue reached $159.51B in 2025, though profit margins have declined from 10.87% in 2022 to 9.28% currently. Institutional activity shows mixed positioning with some funds increasing while others reducing holdings.

The stock presents a compelling value opportunity with a consensus price target of $379.93 representing 33% upside potential. However, weakening profit margins, rising mortgage rates impacting housing demand, and bearish technical indicators create near-term headwinds. Long-term prospects remain supported by professional segment growth and housing market tailwinds.

Zoetis Inc

Zoetis (ZTS) trades at $71.55, showing modest daily gains of 0.32% amid a challenging market environment. The stock faces bearish technical signals with mixed quarterly earnings performance - beating expectations in Q2 2026 but missing in Q1. Strong fundamentals persist with 71.67% gross margins and 27.69% net income margins, though recent headwinds include U.S. companion animal market weakness and increased competition in key therapeutic areas. The company maintains robust cash flow generation with $2.9 billion from operations in 2025.

Despite near-term pressures, ZTS presents value opportunity with attractive valuation at 11.67 P/E ratio and consensus price target of $87.33 suggesting 22% upside. Risks include ongoing competitive pressures and U.S. market softness, but industry-leading profitability and international growth provide stability. Analyst sentiment remains positive with no sell ratings among 32 covering firms, though technical indicators suggest cautious near-term positioning.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HD
100% Buy0% Sell
Avg holding period · 139 Days
ZTS

No sentiment data available yet.

Top news

Latest headlines on both assets

About Home Depot Inc

Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.

Read more on HD →

About Zoetis Inc

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Read more on ZTS →